Results 131 to 140 of about 4,397 (174)
From Platelet Toxicity to Precision Targeting: Evolving Strategies to Overcome Thrombocytopenia in BCL-2/BCL-XL Inhibition. [PDF]
Mohiuddin M.
europepmc +1 more source
Endomitosis: a new cell fate in the cell cycle leading to polyploidy in megakaryocytes and hepatocytes. [PDF]
Hua QH, Zhang X, Tian R, She Z, Huang Z.
europepmc +1 more source
Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment. [PDF]
Peshin S +5 more
europepmc +1 more source
Immune and Inflammatory Properties of Megakaryocytes. [PDF]
Singh SV, Lucerne A, Ravid K.
europepmc +1 more source
The Role of Megakaryocyte Assessment in Bone Marrow Cytology. [PDF]
Błocka-Gumowska M, Hus I, Szymczyk A.
europepmc +1 more source
Paediatric Acute Myeloid Leukaemia-Myelodysplasia Related With i(17)(q10) Morphologically Mimicking Acute Promyelocytic Leukaemia. [PDF]
De John K +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cytokine control of megakaryopoiesis
Growth Factors, 2018Platelets are anuclear blood cells required for haemostasis and are implicated in other processes including inflammation and metastasis. Platelets are produced by megakaryocytes, specialized cells that are themselves generated by a process of controlled differentiation and maturation of bone-marrow stem and progenitor cells.
Kira Behrens
exaly +3 more sources
Interferon-γ and Human Megakaryopoiesis
Leukemia and Lymphoma, 1998Interferon-gamma (IFN-gamma) exhibits various properties including antigrowth activity in neoplastic and normal cells and regulatory roles in immune responses and hematopoiesis, but studies of IFN-gamma effects on human megakaryopoiesis have been inconclusive.
Kohichiro Tsuji, T Nakahata
exaly +3 more sources

